SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-001584
Filing Date
2015-08-10
Accepted
2015-08-10 17:06:41
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20150630x10q.htm 10-Q 1263411
2 EX-31.1 bpmc-20150630ex3114dca02.htm EX-31.1 22736
3 EX-31.2 bpmc-20150630ex312e3349f.htm EX-31.2 22718
4 EX-32.1 bpmc-20150630ex321b2b448.htm EX-32.1 15727
  Complete submission text file 0001558370-15-001584.txt   5476139

Data Files

Seq Description Document Type Size
5 EX-101.INS bpmc-20150630.xml EX-101.INS 1148585
6 EX-101.SCH bpmc-20150630.xsd EX-101.SCH 38809
7 EX-101.CAL bpmc-20150630_cal.xml EX-101.CAL 36000
8 EX-101.DEF bpmc-20150630_def.xml EX-101.DEF 204690
9 EX-101.LAB bpmc-20150630_lab.xml EX-101.LAB 409246
10 EX-101.PRE bpmc-20150630_pre.xml EX-101.PRE 297898
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 151041618
SIC: 2834 Pharmaceutical Preparations